(0.00%) 5 206.75 points
(0.03%) 39 009 points
(-0.07%) 18 183 points
(0.19%) $78.63
(-1.37%) $2.17
(-0.01%) $2 330.90
(-0.12%) $27.58
(0.74%) $972.00
(0.05%) $0.929
(0.27%) $10.85
(0.07%) $0.797
(0.03%) $91.37
2 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 13.74%
-4.01% $ 0.941
Live Chart Being Loaded With Signals
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 118 444 |
Średni wolumen | 101 306 |
Kapitalizacja rynkowa | 32.64M |
EPS | $0 ( 2024-03-21 ) |
Następna data zysków | ( $-0.160 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.450 |
ATR14 | $0.00500 (0.53%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-01 | Behner Peter | Buy | 16 185 | Common Stock |
2024-03-01 | Ryan Barbara | Buy | 18 685 | Common Stock |
2024-03-01 | Wiinberg Ulf | Buy | 15 790 | Common Stock |
2024-03-01 | Corvese Brian | Buy | 18 816 | Common Stock |
2024-01-16 | Van Dijk Marcus Antonius | Buy | 171 078 | Stock Option |
INSIDER POWER |
---|
-43.59 |
Last 97 transactions |
Buy: 6 422 397 | Sell: 29 448 104 |
Wolumen Korelacja
MiNK Therapeutics, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
MMAC | 0.859 |
EPSN | 0.847 |
CLFD | 0.834 |
NETE | 0.828 |
LYRA | 0.825 |
INPX | 0.812 |
DSGN | 0.808 |
NBIX | 0.808 |
AMRB | 0.804 |
REYN | 0.802 |
10 Najbardziej negatywne korelacje | |
---|---|
RMRM | -0.834 |
CPAA | -0.829 |
TIOAU | -0.826 |
SVAC | -0.818 |
MTSL | -0.817 |
CVCO | -0.814 |
THCP | -0.813 |
AEAE | -0.813 |
PAIC | -0.813 |
TIOA | -0.81 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
MiNK Therapeutics, Inc. Korelacja - Waluta/Towar
MiNK Therapeutics, Inc. Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-204 617 (0.00 %) |
EPS: | $-0.650 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-204 617 (0.00 %) |
EPS: | $-0.650 |
FY | 2022 |
Przychody: | $2.70B |
Zysk brutto: | $-28.24B (-1 044.26 %) |
EPS: | $-0.740 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.160 |
Financial Reports:
No articles found.
MiNK Therapeutics, Inc.
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases, which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York. MiNK Therapeutics, Inc. operates as a subsidiary of Agenus Inc.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej